ANNX insider transaction filings
Annexon, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen ANNX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Blumenkranz Mark S. — Director | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Cockroft Bettina M. — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Carson William H. — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Yednock Ted — EVP & CHIEF INNOVATION OFFICER | Option exercise (M): 30,646 @ $1.85 · Option exercise (M): 30,646 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Choi Jung — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Waddill William D. — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | JONES WILLIAM A JR — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Satter Muneer A — Director | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Satter Muneer A — Director | Purchase (P): 613,497 @ $5.41 | EDGAR |
| 2026-05-13 | 4 | Carson William H. — Director | Purchase (P): 8,000 @ $5.78 | EDGAR |
| 2026-04-14 | 4 | Carson William H. — Director | Purchase (P): 8,000 @ $6.20 | EDGAR |
| 2026-03-12 | 4 | Carson William H. — Director | Purchase (P): 8,000 @ $5.67 | EDGAR |
| 2026-03-04 | 4 | ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER | Sale (S): 5,894 @ $5.43 | EDGAR |
| 2026-03-04 | 4 | Yednock Ted — EVP & CHIEF INNOVATION OFFICER | Sale (S): 5,566 @ $5.42 | EDGAR |
| 2026-03-04 | 4 | Overdorf Michael — EVP & CHIEF BUSINESS OFFICER | Sale (S): 4,339 @ $5.42 | EDGAR |
| 2026-03-04 | 4 | Dananberg Jamie — CHIEF MEDICAL OFFICER | Sale (S): 5,820 @ $5.43 | EDGAR |
| 2026-03-04 | 4 | Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER | Sale (S): 5,565 @ $5.42 | EDGAR |
| 2026-02-23 | 4 | ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER | Grant/award (A): 62,500 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Yednock Ted — EVP & CHIEF INNOVATION OFFICER | Grant/award (A): 62,500 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Overdorf Michael — EVP & CHIEF BUSINESS OFFICER | Grant/award (A): 62,500 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Love Douglas — PRESIDENT AND CEO, Director | Grant/award (A): 1,250,000 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Dananberg Jamie — CHIEF MEDICAL OFFICER | Grant/award (A): 56,250 @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER | Grant/award (A): 62,500 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER | Sale (S): 5,290 @ $5.10 | EDGAR |
| 2026-02-20 | 4 | Yednock Ted — EVP & CHIEF INNOVATION OFFICER | Sale (S): 7,857 @ $5.11 | EDGAR |
| 2026-02-20 | 4 | Overdorf Michael — EVP & CHIEF BUSINESS OFFICER | Sale (S): 6,225 @ $5.10 | EDGAR |
| 2026-02-20 | 4 | Dananberg Jamie — CHIEF MEDICAL OFFICER | Sale (S): 5,290 @ $5.10 | EDGAR |
| 2026-02-20 | 4 | Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER | Sale (S): 7,851 @ $5.11 | EDGAR |
| 2026-01-02 | 4 | Carson William H. — Director | Purchase (P): 4,115 @ $5.02 | EDGAR |
| 2025-12-03 | 4 | Carson William H. — Director | Purchase (P): 4,115 @ $4.47 | EDGAR |
| 2025-12-03 | 4 | Choi Jung — Director | Purchase (P): 33,000 @ $4.19 | EDGAR |
| 2025-11-21 | 4 | Satter Muneer A — Director | Purchase (P): 400,000 @ $4.48 · Purchase (P): 422,613 @ $4.28 | EDGAR |
| 2025-11-19 | 4 | Satter Muneer A — Director | Purchase (P): 500,000 @ $2.99 · Purchase (P): 500,000 @ $3.18 · Purchase (P): 500,000 @ $3.94 | EDGAR |
| 2025-10-31 | 4 | Carson William H. — Director | Purchase (P): 4,115 @ $3.17 | EDGAR |
| 2025-10-02 | 4 | Carson William H. — Director | Purchase (P): 4,115 @ $3.05 | EDGAR |
| 2025-09-04 | 4 | Carson William H. — Director | Purchase (P): 4,115 @ $2.09 | EDGAR |
| 2025-08-01 | 4 | Carson William H. — Director | Purchase (P): 4,115 @ $2.43 | EDGAR |
| 2025-07-16 | 4 | Yednock Ted — EVP & CHIEF INNOVATION OFFICER | Sale (S): 1,116 @ $2.58 | EDGAR |
| 2025-07-16 | 4 | Overdorf Michael — EVP & CHIEF BUSINESS OFFICER | Sale (S): 853 @ $2.61 | EDGAR |
| 2025-07-16 | 4 | Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER | Sale (S): 1,117 @ $2.58 | EDGAR |
| 2025-07-01 | 4 | Carson William H. — Director | Purchase (P): 4,115 @ $2.46 | EDGAR |
| 2025-06-09 | 4 | Waddill William D. — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Carson William H. — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Choi Jung — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Cockroft Bettina M. — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | JONES WILLIAM A JR — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Satter Muneer A — Director, 10% owner | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | WIGGANS THOMAS G — Director | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER | Grant/award (A): 44,963 @ $0 · Grant/award (A): 272,575 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Dananberg Jamie — CHIEF MEDICAL OFFICER | Grant/award (A): 44,963 @ $0 · Grant/award (A): 228,225 (derivative) @ $0 | EDGAR |
Recent 8-K events — Annexon, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ANNX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →